Access cutting-edge nicotine dependence treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access nicotine dependence specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related nicotine dependence treatment provided free
The advent of anti-retroviral therapy (ART) for people living with HIV/AIDS (PLWHA) substantially improved life expectancy but has also led to the critical need to address modifiable risk factors associated with cancer and cardiovascular disease, such as tobacco smoking. HIV-infected smokers lose more life-years due to tobacco use than they do to their HIV infection. There have been relatively few studies of tobacco use treatments for PLWHA and systematic reviews show that there are insufficien
Sponsor: University of Pennsylvania
Check if you qualify for this nicotine dependence clinical trial in Philadelphia, PA
If you're searching for nicotine dependence treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced nicotine dependence specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.